Intervention Ultrasonography
Conditions
Interventions
0.375% ropivacaine injection in the doses of 2.5 ml in each ventricle of the anterior and middle scolenes muscles, guided by ultrasonography,compared to the skin touch with the same syringe-needle set
Drug
Sponsors
Instituto de Medicina Fisica e Reabilitação - IMREA - HCFMUSP
Instituto de Ortopedia e Traumatologia – IOT da Faculdade de Medicina da Universidade de São Paulo.
Eligibility
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: this study were subjects with a diagnosis of nonspecific, Thoracic Outlet Syndrome who included criteria for inclusion with pain in upper limbs and / or neck pain without radiculopathy or neurological impairment of the limb in question due to compressive or encephalic root causes.
Exclusion criteria
Exclusion criteria: Clinical instability with acute medical conditions. Hypersensitivity to administered medication. Injury of the rotator cuff previously diagnosed by some imaging examination and justifying pain. Fibromyalgia previously diagnosed.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| CHARACTERISTICS OF THE ARM, SHOULDER AND HAND presentation of the method used to verify the expected result: DASH scale - DISABILITIES OF THE ARM, SHOULDER, AND HAND; presentation of the parameters: percentage, average along the scale, used for the actual final result. Improvement of the functionality in 1 year, verified through the DASH chart, from the observation of a variation of at least 5% in the pre- and post-intervention evaluations. | — |
Secondary
| Measure | Time frame |
|---|---|
| Pain improvement at 1 year, verified through the Visual Analogue Scale (EVA) scale. a) Assuming a variation of at least 5% in pre and post-intervention measurements. | — |
Countries
Brazil
Contacts
Public ContactChennyfer;CHENNYFER Rached;RACHED
Universidade Nove de Julho;Universidade Nove de Julho
Outcome results
None listed